Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Angiotensinogen
Tanvir Kahlon, Samantha M. Carlisle, Diana Otero Mostacero, et al.
JACC Heart Failure (2022) Vol. 10, Iss. 10, pp. 699-713
Open Access | Times Cited: 23

Showing 23 citing articles:

Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension
Akshay S. Desai, David J. Webb, Jörg Täubel, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 3, pp. 228-238
Open Access | Times Cited: 153
Sensing, Imaging, and Therapeutic Strategies Endowing by Conjugate Polymers for Precision Medicine
Qi Shen, Gang Song, Hongrui Lin, et al.
Advanced Materials (2024) Vol. 36, Iss. 19
Closed Access | Times Cited: 22
A peptide from Boletus griseus‐Hypomyces chrysospermus protects against hypertension and associated cardiac and renal damage through modulating RAAS and intestinal microbiota
Pengtao Huan, Liping Sun, Shupeng Chen, et al.
Journal of Food Science (2025) Vol. 90, Iss. 1
Closed Access | Times Cited: 2
Metabolomics as a critical tool for deeper understanding of pickled foods: From biomarker discovery to nutrition function
Chenna Di, Wei Jia
Trends in Food Science & Technology (2024) Vol. 147, pp. 104456-104456
Closed Access | Times Cited: 7
Dysfunction of the renin-angiotensin-aldosterone system in human septic shock
Christopher L. Schaich, Daniel E. Leisman, Marcia B. Goldberg, et al.
Peptides (2024) Vol. 176, pp. 171201-171201
Closed Access | Times Cited: 5
A Bibliometric Analysis of hypertension and anxiety from 2004 to 2022
S Liu, Xin-Yu Ji, Hai-Yi Liang, et al.
Medicine (2025) Vol. 104, Iss. 13, pp. e41859-e41859
Open Access
Silencing Angiotensinogen in Hypertension
Rhian M. Touyz
New England Journal of Medicine (2023) Vol. 389, Iss. 3, pp. 278-281
Closed Access | Times Cited: 12
Stronger association of intact angiotensinogen with mortality than lactate or renin in critical illness: post-hoc analysis from the VICTAS trial
Mark C. Chappell, Christopher L. Schaich, Laurence W. Busse, et al.
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 4
Clinical studies in Myxomatous Mitral Valve Disease dogs: most prescribed ACEI inhibits ACE2 enzyme activity and ARB increases AngII pool in plasma
Smruti K. Nair, Henry Daniell, Elliot V. Hersh, et al.
Hypertension Research (2025)
Open Access
Proteomic Insights Into Early Detection and Progression of Knee Osteoarthritis: Unveiling Molecular Signatures
Bhavneet Kaur, Diksha Rana, Rinkle Sharma, et al.
Archives of Medical Research (2025) Vol. 56, Iss. 5, pp. 103206-103206
Closed Access
Blood Levels of Angiotensinogen and Hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA)
Patrick Trainor, Michela Brambatti, Samantha M. Carlisle, et al.
Journal of the American College of Cardiology (2023) Vol. 81, Iss. 13, pp. 1248-1259
Open Access | Times Cited: 10
Use of Genomics to Develop Novel Therapeutics and Personalize Hypertension Therapy
Emma Magavern, Vikas Kapil, Manish Saxena, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2024) Vol. 44, Iss. 4, pp. 784-793
Closed Access | Times Cited: 3
Novel Therapies for the Treatment of Cardiovascular Disease
Abdul Aziz Asbeutah, Zachary D. Goldberger
Medical Clinics of North America (2024) Vol. 108, Iss. 5, pp. 953-964
Closed Access | Times Cited: 2
Emerging RNAi Therapies to Treat Hypertension
Pawan Daga, Gurnoor Singh, Tushar Menon, et al.
Molecular Diagnosis & Therapy (2024)
Closed Access | Times Cited: 2
System Analysis Based on Lipid-Metabolism-Related Genes Identifies AGT as a Novel Therapy Target for Gastric Cancer with Neoadjuvant Chemotherapy
Le Zhu, Ming Ma, Lumin Zhang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 810-810
Open Access | Times Cited: 6
Inhibition of angiotensinogen in the treatment of hypertension
Eugene Braunwald
European Heart Journal (2023) Vol. 44, Iss. 47, pp. 4909-4910
Closed Access | Times Cited: 5
Early initiation of ARBs without blood pressure risk via neutrophil membrane-fused pH-sensitive liposomes to reduce cardiomyocyte apoptosis after acute myocardial infarction
Jinfeng Gao, Wusiman Yakufu, Hongbo Yang, et al.
Nano Research (2023) Vol. 16, Iss. 7, pp. 9894-9905
Closed Access | Times Cited: 4
Silencing liver angiotensinogen synthesis as a novel approach to hypertension management: promises and challenges
Giovanna Liuzzo, Massimo Volpe
European Heart Journal (2023) Vol. 44, Iss. 40, pp. 4217-4219
Open Access | Times Cited: 2
Stronger association of intact angiotensinogen with mortality than lactate or renin in critical illness – post-hoc analysis from the VICTAS trial
Mark C. Chappell, Christopher L. Schaich, Laurence W. Busse, et al.
Research Square (Research Square) (2024)
Closed Access
Identification of Estrogen-Responsive Proteins in Mouse Seminal Vesicles Through Mass Spectrometry-Based Proteomics
Ammar Kapic, Khadiza Zaman, Vien Nguyen, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1508-1508
Open Access
Angiotensinogen and angiotensins
Massimo Volpe, Speranza Rubattu
Elsevier eBooks (2024)
Closed Access
The Angiotensin Metabolite His-Leu Is a Strong Copper Chelator Forming Highly Redox Active Species
Nina E. Wezynfeld, Dobromiła Sudzik, Aleksandra Tobolska, et al.
Inorganic Chemistry (2024) Vol. 63, Iss. 26, pp. 12268-12280
Open Access
Identification of immune- and oxidative stress-related signature genes as potential targets for mRNA vaccines for pancreatic cancer patients
Jiaxu Li, Yongjiao Han, Ning Zhao, et al.
Medicine (2024) Vol. 103, Iss. 27, pp. e38666-e38666
Open Access
Page 1

Scroll to top